Rutgers Entrepreneurs is hosting a virtual event with Dr. Andy Brooks, developer of the Rutgers/RUCDR COVID-19 Saliva Test and CEO at Infinity Biologix, the $44M Rutgers spinout on Monday, December 14th at noon. We will discuss the evolution of the RUCDR lab, deployment of the COVID-19 Saliva Test during the pandemic, and the spinout of Infinity Biologix.
You can register here for the event.
Information is also available on our new Entrepreneurship Partnerships web site: go.rutgers.edu/Rutgerspreneurs. (You’ll also see our first “Rutgers Entrepreneur Highlight” featuring alum Lou Cooperhouse at BlueNalu on the new web site!)
The event is co-sponsored by the Rutgers University Alumni Association.
Any questions – please contact Pavita Howe: email@example.com